CompaniesAeris Therapeutics

Aeris Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (18)
View all

Total Trials

18

As Lead Sponsor

18

As Collaborator

0

Total Enrollment

934

By Phase

PHASE3: 3PHASE4: 1PHASE2/PHASE3: 2PHASE1/PHASE2: 2PHASE1: 4PHASE2: 4

By Status

COMPLETED: 9TERMINATED: 7WITHDRAWN: 2
Clinical Trials Pipeline18 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
Today
NCT00205907
NCT00085852
NCT00205920
NCT00435253
NCT00517998
NCT00515164
NCT00630227
NCT01051258
NCT01449175
NCT01320566
NCT01520064
NCT01520740
Hover over trial bars to see details

Recent Trials

NCT01908933Lead Sponsor
Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema
PHASE3Withdrawn
Started: Sep 30, 2013 · Completed: Nov 30, 2013
NCT01449292Lead Sponsor
Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)
PHASE3Terminated
300 participants
Started: Jun 30, 2012 · Completed: Nov 30, 2013
NCT01520064Lead Sponsor
Post Market Registry Study of the AeriSeal System
N/ATerminated
25 participants
Started: Feb 29, 2012 · Completed: Nov 30, 2013
NCT01520740Lead Sponsor
Collateral Ventilation Effects on Response to AeriSeal System Treatment in Upper Lobe Predominant Emphysema
PHASE4Terminated
100 participants
Started: Feb 29, 2012 · Completed: Nov 30, 2013
NCT01320566Lead Sponsor
A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema
PHASE2/PHASE3Terminated
18 participants
Started: Mar 31, 2011 · Completed: Nov 30, 2013
View all 18 trials →
Related Companies
Pulmonx Jan 2015----------------------------------------if You Believe Any Of This Information Is Incorrect
acquired